We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Genetically Engineered Maggots Could Augment Wound Healing

By HospiMedica International staff writers
Posted on 03 Apr 2016
Print article
Image: L. sericata larvae produce and secrete a human growth factor (Photo courtesy of Max Scott/NCSU).
Image: L. sericata larvae produce and secrete a human growth factor (Photo courtesy of Max Scott/NCSU).
A new study describes how maggot debridement therapy (MDT) larvae can be genetically modified to release a human growth factor that actively stimulates cell growth and wound healing.

Researchers at North Carolina State University (NCSU; Raleigh, USA) and Massey University (Wellington, New Zealand) developed a concept MDT technology that is based on transgenic strains of Lucilia sericata (green bottle fly) larvae that express and secrete human platelet derived growth factor-BB (PDGF-BB) at detectable levels in adult hemolymph, whole larval lysate, and maggot excretions/secretions (ES), with the potential for clinical utility in wound healing.

The researchers engineered transgene insertion in several strains of L. sericata, and tried two ways to make the maggots produce and secrete PDGF-BB. First, they engineered maggots that produce the PDGF-BB when they are shocked with heat up to 37 °C; but while heat made the maggots produce the hormone, they did not release it. The other system, which mediated PDGF-BB expression by raising the maggots on a diet that lacked tetracycline, was more successful, resulting in high levels of the growth factor. The study was published on March 22, 2106, in BMC Biotechnology.

“We see this as a proof-of-principle study for the future development of engineered L. sericata strains that express a variety of growth factors and antimicrobial peptides with the long-term aim of developing a cost-effective means for wound treatment that could save people from amputation and other harmful effects of diabetes,” said lead author Professor of Entomology Max Scott, PhD, of NCSU. “Most people with diabetes live in less wealthy countries with little access to expensive treatments, and MDT could offer them an effective and accessible alternative.”

Human PDGF-BB is a secreted dimeric peptide growth factor that stimulates cell proliferation and survival, promotes wound healing, and has been investigated as a possible topical treatment for non-healing wounds. Genetic engineering has allowed for the expression and secretion of human growth factors and other proteins in transgenic insects.

Related Links:

North Carolina State University
Massey University


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Radial Shock Wave Device
MASTERPULS »ultra«

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more